Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Paul Tam"'
Publikováno v:
Nephron. 137(3)
Background: Chronic kidney disease (CKD) is a leading cause of morbidity and mortality. Biomarkers that predict end-stage renal disease (ESRD) and/or mortality could usher in new therapeutics to halt this onslaught. While fibroblast growth factor (FG